Literature DB >> 17111201

Left main coronary thrombosis with essential thrombocythemia.

Zekeriya Nurkalem1, Nevzat Uslu, Sevket Gorgulu, Mehmet Eren.   

Abstract

Essential thrombocythemia is a disorder that causes persistent increase in the platelet count. The disease is associated with an elevated risk of thrombosis. A 71-year-old woman was diagnosed with left main coronary thrombosis after an angiogram due to stable angina. One week before the angiogram was taken the patient had also been diagnosed with essential thrombocythemia. After appropriate medical treatment for 5 days the patient underwent an excimer laser treatment, which failed in dissolving the thrombus. Before the patient underwent coronary surgery, thrombopheresis was performed in order to reduce the platelet count. After a successful coronary operation the patient improved completely.

Entities:  

Mesh:

Year:  2006        PMID: 17111201     DOI: 10.1007/s11239-006-9016-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  9 in total

1.  Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.

Authors:  C N Harrison; S Donohoe; P Carr; M Dave; I Mackie; S J Machin
Journal:  Thromb Haemost       Date:  2002-05       Impact factor: 5.249

2.  Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation.

Authors:  P J van Genderen; I S Lucas; R van Strik; V D Vuzevski; F J Prins; H H van Vliet; J J Michiels
Journal:  Thromb Haemost       Date:  1996-09       Impact factor: 5.249

3.  Multivessel coronary thrombosis treated with abciximab (ReoPro) in a patient with essential thrombocythemia.

Authors:  A D Michaels; B Whisenant; J S MacGregor
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

4.  A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications.

Authors:  C N Harrison; R E Gale; S J Machin; D C Linch
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

5.  Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial).

Authors:  On Topaz; Douglas Ebersole; Tony Das; Edwin L Alderman; Hooman Madyoon; Kishor Vora; John D Baker; David Hilton; Johannes B Dahm
Journal:  Am J Cardiol       Date:  2004-03-15       Impact factor: 2.778

Review 6.  Essential thrombocythemia-related acute ST-segment elevation myocardial infarction. A case report and literature review.

Authors:  Samantapudi K Daya; Ramesh M Gowda; William A Landis; Ijaz A Khan
Journal:  Angiology       Date:  2004 May-Jun       Impact factor: 3.619

7.  Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

Authors:  S Cortelazzo; P Viero; G Finazzi; A D'Emilio; F Rodeghiero; T Barbui
Journal:  J Clin Oncol       Date:  1990-03       Impact factor: 44.544

8.  Increased thromboxane biosynthesis in essential thrombocythemia.

Authors:  B Rocca; G Ciabattoni; R Tartaglione; S Cortelazzo; T Barbui; C Patrono; R Landolfi
Journal:  Thromb Haemost       Date:  1995-11       Impact factor: 5.249

9.  Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.

Authors:  Francesco Passamonti; Elisa Rumi; Ester Pungolino; Lucia Malabarba; Paola Bertazzoni; Marina Valentini; Ester Orlandi; Luca Arcaini; Ercole Brusamolino; Cristiana Pascutto; Mario Cazzola; Enrica Morra; Mario Lazzarino
Journal:  Am J Med       Date:  2004-11-15       Impact factor: 4.965

  9 in total
  8 in total

1.  Treatment of a large left main coronary artery thrombus by aspiration thrombectomy.

Authors:  Petr Hajek; David Alan; Jiri Vejvoda; Katerina Linhartova; Petr Skapa; Zdenka Hajsmannova; Josef Veselka
Journal:  J Thromb Thrombolysis       Date:  2008-03-10       Impact factor: 2.300

2.  Off-pump myocardial revascularization in a high-risk patient with essential thrombocythemia.

Authors:  Ahmad K Darwazah; Hamad Madi; Rami Zagha; Yahia Hawash
Journal:  Tex Heart Inst J       Date:  2014-10-01

3.  Left main coronary artery thrombosis revealing angio-Behçet syndrome.

Authors:  Jihen Ayari; Mohamed S Mourali; Abdjalil Farhati; Rachid Mechmeche
Journal:  Egypt J Intern Med       Date:  2014

4.  Excimer laser debulking for percutaneous coronary intervention in left main coronary artery disease.

Authors:  On Topaz; Pritam R Polkampally; Pramod K Mohanty; Maged Rizk; Julie Bangs; Nelson L Bernardo
Journal:  Lasers Med Sci       Date:  2009-02-24       Impact factor: 3.161

5.  Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case report.

Authors:  Young-Hyo Lim; Young Yiul Lee; Jae Hoon Kim; Jinho Shin; Jae Ung Lee; Kyung-Soo Kim; Soon-Kil Kim; Jeong Hyun Kim; Heon Kil Lim
Journal:  Korean J Hematol       Date:  2010-06-30

Review 6.  Extreme thrombocytosis and cardiovascular surgery: risks and management.

Authors:  Ethan A Natelson
Journal:  Tex Heart Inst J       Date:  2012

7.  Emergency cardiac surgery and heparin resistance in a patient with essential thrombocythemia.

Authors:  Mika Nakanishi; Eri Oota; Takehiro Soeda; Kaoru Masumo; Yukihiko Tomita; Takeshi Kato; Toshihiro Imanishi
Journal:  JA Clin Rep       Date:  2016-11-09

8.  Coronary artery bypass graft for stent occlusion in a patient with essential thrombocythemia.

Authors:  Nael Al-Sarraf
Journal:  J Surg Case Rep       Date:  2021-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.